123I radiolabeling of monoclonal antibodies for in vivo procedures. 1986

S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher

When labeled to monoclonal antibodies (MAbs) or their fragments, 123I can be used for imaging or for predicting the treatment potential and radiation dosimetry of 131I labeled to the same molecular species. Because 123I (p,5n) from the Crocker Nuclear Laboratory is in dilute solution, when compared with commercial 125I of labeling grade, we have evaluated labeling parameters using Chloramine-T as the oxidant and derived an optimum set of labeling conditions that provide a 60-80% radiochemical yield of highly immunoreactive antibody. When Lym-1, an IgG-2a murine antibody against human lymphoma, was used, yields of labeled immunoglobulin were decreased by protein or Chloramine-T concentrations less than 0.4 microgram/microliter and 0.8 microgram/microliter, respectively; denaturation of the immunoglobulin occurred when the Chloramine-T concentration was greater than 1.0 microgram/microliter. Optimum labeling occurred at pH 7-8 with deleterious effects when the pH was below 5 or above 10. An optimum method for labeling antibodies with multimillicurie amounts of 123I (less than one iodine atom per 100 antibody molecules) is described. Some of the observations derived from this study are also applicable to the preparation of treatment doses of 131I-labeled antibodies, wherein the amount of antibody can be a restrictive factor.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D011865 Radioisotope Dilution Technique Method for assessing flow through a system by injection of a known quantity of radionuclide into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed) Radioisotope Dilution Technic,Dilution Technic, Radioisotope,Dilution Technics, Radioisotope,Dilution Technique, Radioisotope,Dilution Techniques, Radioisotope,Radioisotope Dilution Technics,Radioisotope Dilution Techniques,Technic, Radioisotope Dilution,Technics, Radioisotope Dilution,Technique, Radioisotope Dilution,Techniques, Radioisotope Dilution
D002700 Chloramines Inorganic derivatives of ammonia by substitution of one or more hydrogen atoms with chlorine atoms or organic compounds with the general formulas R2NCl and RNCl2 (where R is an organic group). Chloroamines
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014105 Tosyl Compounds Toluenesulfonyl compounds with general formula CH3C6H4S(O2)R” widely used to block amino groups in the course of syntheses of drugs and other biologically active compounds. Toluenesulfonyl Compounds,Compounds, Toluenesulfonyl,Compounds, Tosyl

Related Publications

S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
July 1986, Hybridoma,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 2000, Methods in molecular medicine,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 2017, BioMed research international,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 1993, Cancer treatment and research,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
May 2002, Nuclear medicine and biology,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
November 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 2000, Bioorganic & medicinal chemistry,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
January 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
S L Mills, and S J Denardo, and G L Denardo, and A L Epstein, and J S Peng, and D Colcher
December 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!